BackTerns Pharmaceuticals Overview
Terns Pharmaceuticals Inc

Terns Pharmaceuticals Discounted Cash Flow

DCF Analysis for TERN.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$5.62

Current Fair Value

$5.62
89.4% Downside

Overvalued by 89.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading